Angers S, Salahpour A, Joly E, et al (2000) Detection of beta2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci 97:3684-3689.

Angers S, Salahpour A, Bouvier M (2002) Dimerization: an emerging concept for G proteincoupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol 42:409-435.

Backstrom JR, Westphal RS, Canton H, et al (1995) Identification of rat serotonin 5-HT2C receptors as glycoproteins containing N-linked oligosaccharides. Mol Brain Res 33:311-318.

Baneres JL, Parello J (2003) Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. J Mol Biol 329:815-829.

Bastiaens PI, Majoul IV, Verveer PJ, et al (1996) Imaging the intracellular trafficking and state of the AB5 quaternary structure of cholera toxin. EMBO J 15:4246-4253.

Benkirane M, Jin DY, Chun RF, et al (1997) Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32. J Biol Chem 272:30603-30606.

Berthouze M, Rivail L, Lucas A, et al (2007) Two transmembrane Cys residues are involved in 5-HT4 receptor dimerization. Biochem Biophys Res Commun 11:642-647.

Briddon SJ, Hill SJ (2008) Pharmacology under the microscope: the use of fluorescence correlation spectroscopy to determine properties of ligand-receptor complexes. Trends Pharmacol Sci 28:637-645.

Burns CM, Chu H, Rueter SM, et al (1997) Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 387:303-308.

Canals M, Burgueno J, Marcellino D, et al (2004) Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J Neurochem 88:726-734.

Canton H, Emeson RB, Barker EL, et al (1996) Identification, molecular cloning, and distribution of a short variant of the 5-Hydroxytryptamine2C receptor produced by alternative splicing. Mol Pharmacol 50:799-807.

Carrillo JJ, Lopez-Gimenez JF, Milligan G (2004) Multiple interactions between transmembrane helices generate the oligomeric a1b-adrenoceptor. Mol Pharmacol 66:1123-1137.

Chen J, Muller JD (2007) Determining the stoichiometry of protein heterocomplexes in living cells with fluorescence fluctuation spectroscopy. PNAS 104:3147-3152.

Cherezov V, Rosenbaum EM, Hanson MA (2007) High resolution crystal structure of an engineered human beta2-adrenercig C protein-coupled receptor. Science 318:1258-1265.

Cornea A, Janovick JA, Maya-Nunez G, et al (2001) Gonadotropin-releasing hormone receptor microaggregation. Rate monitored by fluorescence resonance energy transfer. J Biol Chem 276:2153-2158.

Cvejic S, Devi LA (1997) Dimerization of the delta opioid receptor: implication for a role in receptor internalization. J Biol Chem 272:26959-26964.

Dinger MC, Bader JE, Kobor AD, et al (2003) Homodimerization of neuropeptide y receptors investigated by fluorescence resonance energy transfer in living cells. J Biol Chem 278:10562-10571.

Fan T, Varghese G, Nguyen T., et al (2005) A role for the distal carboxy tails in generating the novel pharmacology and G-protein activation profile of Mu and delta opiod receptor heteroo-ligomers. J Biol Chem 280:38478-38488.

Farrens DL, Altenbach C, Yang K, et al (1996) Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 274:768-770.

Fitzgerald LW, Iyer G, Conklin DS, et al (1999) Messenger RNA editing of the human serotonin 5-HT2C receptor. Neuropsychopharmacology 21:82s-90s.

Fotiadis DM, Jastrzebska B, Philippsen A, et al (2006) Structure of the rhodopsin dimer: a working model for G-protein-coupled receptors. Curr Opin Struct Biol 16:252-259.

George SR, O'Dowd BF, Lee S (2002) G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat Rev Drug Discov 1:808-820.

Gether U, Lin S, Ghanouni P, et al (1997) Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor. EMBO J 16:6737-6747.

Goudet C, Kniazeff J, Hlavackova V, et al (2005) Asymmetric functioning of dimeric metabotro-pic glutamate receptors disclosed by positive allosteric modulators. J Biol Chem 280:24380-24385.

Grosse R, Schoneberg T, Schultz G, et al (1997) Inhibition of gonadotropin-releasing hormone receptor signaling by expression of a splice variant of the human receptor. Mol Endocrinol 11:1305-1318.

Guest PC, Salim K, Skynner HA, et al (2000) Identification and characterization of a truncated variant of the 5-hydroxytryptamine2A receptor produced by alternative splicing. Brain Res 876:238-244. 2A

Guo W, Shi L, Filizola M, et al (2005) Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. Proc Natl Acad Sci 102:17495-17500.

Hamm HE (2001) How activated receptors couple to G proteins. Proc Natl Acad Sci 98:4819-4821.

Hebert T E, Moffett S, Morello J P, et al (1996) A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation, J Biol Chem 271:16384-16392.

Herrick-Davis K, Grinde E, Niswender CM (1999) Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction. J Neurochem 73:1711-1717.

Herrick-Davis K, Grinde E, Teitler M (2000) Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors. J Pharmacol Exp Ther 295:226-232.

Herrick-Davis K, Grinde E, Mazurkiewicz JE (2004) Biochemical and biophysical characterization of serotonin 5-HT2C receptor homodimers on the plasma membrane of living cells. Biochemistry 43:13963-13971.

Herrick-Davis K, Grinde E, Harrigan TJ, et al (2005) Inhibition of serotonin 5-hydroxytryptam-ine2C receptor function through heterodimerization: receptor dimers bind two molecules of ligand and one G-protein. J Biol Chem 280:40144-40151.

Herrick-Davis K, Weaver B, Grinde E, et al (2006) Serotonin 5-HT2C receptor homodimer biogenesis in the endoplasmic reticulum: Real-time visualization with confocal fluorescence resonance energy transfer. J Biol Chem 281:27109-27116.

Herrick-Davis K, Weaver BA, Grinde E (2007) Serotonin 5-HT(2C) receptor homodimerization is not regulated by agonist or inverse agonist treatment. Eur J Pharmacol 568:45-53.

Hoyer D, Hannon JP, Martin GR (2002) Molecular pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533-554.

Ianoul A, Grant DD, Rouleau Y, et al (2005) Imaging nanometer domains of beta-adrenergic receptor complexes on the surface of cardiac myocytes. Nat Chem Biol 1:196-202.

Javitch JA (2004) The ants go marching two by two: oligomeric structure of G-protein-coupled receptors. Mol Pharmacol 66:1077-1082.

Jones BJ, Blackburn TP (2002) The medical benefit of 5-HT research. Pharmacol Biochem Behav 71:555-568.

Jones KA, Borowsky B, Tamm, JA, et al (1998) GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature 396:674-679.

Karpa KD, Lin R, Kabbani N, et al (2000) The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf: D3-D3nf interaction causes mislocalization of D3 receptors. Mol Pharmacol 58:677-683.

Kaupmann K, Malitschek B, Schuler V, et al (1998) GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature 396:683-687.

Kenworthy AK, Edidin M (1998) Distribution of a glycosylphosphatidylinositol-anchored protein at the apical surface of MDCK cells examined at a resolution of <100 A using imaging fluorescence resonance energy transfer. J Cell Biol 142:69-84.

Kerppola TK (2008) Bimolecular fluorescence complementation (BiFC) analysis as a probe of protein interaction in living cells. Annu Rev Biophys 37:465-487.

Klco JM, Lassere TB, Baranski TJ (2003) C5a receptor oligomerization. Disulfide trapping reveals oligomers and potential contact surfaces in a G-protein-coupled receptor. J Biol Chem 278:35345-35353.

Li Z, Ichikawa J, Huang M, et al (2005) ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Psychopharmacology 183:144-153.

Liang Y, Fotiadis D, Filipek S, et al (2003) Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J Biol Chem 278:21655-21662.

Mancia F, Assur Z, Herman AG, et al (2008) Ligand sensitivity in dimeric associations of the serotonin 5HT2c receptor. EMBO Rep 9:363-369.

Margeta-Mitrovic M, Jan YN, Jan LY (2000) A trafficking checkpoint controls GABA(B) receptor heterodimerization. Neuron 27:97-106.

McGrew L, Chang MS, Sanders-Bush E (2002) Phospholipase D activation by endogenous 5-hydroxytryptamine 2C receptors is mediated by Galpha13 and pertussis toxin-insensitive Gbetagamma subunits. Mol Pharmacol 62:1339-1343.

McVey M, Ramsay D, Kellett E, et al (2001) Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer. The human delta -opioid receptor displays constitutive oligomerization at the cell surface, which is not regulated by receptor occupancy. J Biol Chem 276:14092-14099.

Mercier JF, Salahpur A, Angers S, et al (2002) Quantitative assessment of B1- and B2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. J Biol Chem 277:44925-44931.

Mesnier D, Baneres JL (2004) Cooperative conformational changes in a G-protein-coupled receptor dimer, the leukotriene B(4) receptor BLT1. J Biol Chem 279:49664-49670.

Miller KJ (2005) Serotonin 5-ht2c receptor agonists: potential for the treatment of obesity. Mol Interv 5:282-291.

Milligan G (2004) G protein-coupled receptor dimerization: function and ligand pharmacology. Mol Pharmacol 66:1-7.

Ng GY, O'Dowd BF, Lee SP, et al (1996) Dopamine D2 receptor dimers and receptor-blocking peptides. Biochem Biophys Res Commun 227:200-204.

Niswender CM, Copeland SC, Herrick-Davis K, et al (1999) RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J Biol Chem 274:9472-9478.

O'Dowd BF, Ji X, Alijaniaram M, et al (2005) Dopamine receptor oligomerization visualized in living cells. J Biol Chem 280:37225-37235.

Olsen MA, Nawoschik SP, Schurman BR, et al (1999) Identification of a human 5-HT6 receptor variant produced by alternative splicing. Brain Res Mol Brain Res 64:255-263.

Overton MC, Blumer KJ (2002) The extracellular N-terminal domain and transmembrane domains 1 and 2 mediate oliogmerization of a yeast G-protein-coupled receptor. J Biol Chem 277:41463-41472.

Park PS, Filipek S, Wells JW, et al (2004) Oligomerization of G protein-coupled receptors: past, present, and future. Biochemistry 43:15643-15656.

Rocheville M, Lange DC, Kumar U, et al (2000) Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 288:154-157.

Roth BL, Hanizavareh SM, Blum AE (2004) Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders. Psychopharmacology 174:17-24.

Salahpour A, Angers S, Mercier J F, et al (2004) Homodimerization of the beta 2-adrenergic receptor as a pre-requisite for cell surface targeting. J.Biol.Chem 279:33390-33397.

Salim K, Fenton T, Bacha J, et al (2002) Oligomerization of G-protein-coupled receptors shown by selective co-immunoprecipitation. J Biol Chem 277:15482-15485.

Shioda T, Nakayama EE, Tanaka Y, et al (2001) Naturally occurring deletional mutation in the C-terminal cytoplasmic tail of CCR5 affects surface trafficking of CCR5. J Virol 75:3462-3468.

Stanasila L, Perez JB, Vogel H, et al (2003) Oligomerization of the a1a- and a1b-adrenergic receptor subtypes. J Biol Chem 278:40239-40251.

Terrillon A, Bouvier M (2004) Roles of G-protein-coupled receptor dimerization. EMBO Rep 5:30-34.

Terrillon S, Durroux T, Mouillac B, et al (2003) Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. Mol Endocrinol 17:677-691.

Waldhoer M, Fong J, Jones RM, et al (2005) A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. Proc Natl Acad Sci U S A 102:9050-9055.

Wallrabe H, Elangovan M, Burchard A, et al (2003) Confocal FRET microscopy to measure clustering of ligand-receptor complexes in endocytic membranes. Biophys J 85:559-571.

White JH, Wise A, Main MJ, et al (1998) Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature 396:679-682.

Xie Z, Lee S P, O'Dowd B F, et al (1999) Serotonin 5-HT1B and 5-HT1D receptors form homodi-mers when expressed alone and heterodimers when co-expressed. FEBS Letters 456:63-67.

Xu Y, Piston D, Johnson CH (1999) A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins. Proc Natl Acad Sci 96:151-156.

Zawarynski P, Tallerico T, Seeman P, et al (1998) Dopamine D2 receptor dimers in human and rat brain. FEBS Lett 441:383-386.

Zhu X, Wess J (1998) Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function. Biochemistry 37:15773-15784.

Defeat Drugs and Live Free

Defeat Drugs and Live Free

Being addicted to drugs is a complicated matter condition that's been specified as a disorder that evidences in the obsessional thinking about and utilization of drugs. It's a matter that might continue to get worse and become disastrous and deadly if left untreated.

Get My Free Ebook

Post a comment